Results 111 to 120 of about 1,385 (194)

Publication Only

HemaSphere, Volume 9, Issue S1, June 2025.
wiley   +1 more source

Increase in Vascular Endothelial Growth Factor (VEGF) Expression and the Pathogenesis of iMCD-TAFRO

Biomedicines
TAFRO (thrombocytopenia (T), anasarca (A), fever (F), reticulin fibrosis (F/R), renal failure (R), and organomegaly (O)) is a heterogeneous clinical subtype of idiopathic multicentric Castleman disease (iMCD) associated with a significantly poorer ...
Gordan Srkalovic, Sally Nijim, Maya Blanka Srkalovic, David Fajgenbaum   +3 more
doaj   +1 more source

Castleman disease misdiagnosed as immunoglobulin G4-related disease: a case report [PDF]

Castleman disease (CD) and immunoglobulin G4-related disease (IgG4-RD) are rare systemic immune-mediated disorders that share overlapping clinical features, posing significant challenges in differential diagnosis.
Jiashun Zeng, Jun Liu, LiFen Xu, Na Li, Pengjia Wu, Xiaoxia Liu   +5 more
core   +1 more source

Case Report: TAFRO syndrome misdiagnosed as liver cirrhosis due to persistent abdominal distension [PDF]

This report described a male patient presenting with recurrent fever, fatigue, persistent abdominal distension, and diarrhea, who was repeatedly misdiagnosed with decompensated cirrhosis at multiple hospitals.
Caiyan Zhao, Chuan Shen, Fang Liu, Feng Gao, Lan Yang, Luyuan Ma, Luzhuo Ma, Peng Xie, Ruolan Gu, Xiaoting Li, Xuelan Xiao   +10 more
core   +1 more source

EHA2024 Hybrid Congress

HemaSphere, Volume 8, Issue S1, June 2024.
wiley   +1 more source

IgG4-related disease and other fibro-inflammatory conditions [PDF]

IgG4-related disease (IgG4-RD) is a fibro-inflammatory disorder usually characterized by multi-organ involvement. Its pathogenesis is complex and involves genetic and environmental factors, while immune responses usually mediate organ damage and promote ...
Bajema, Ingeborg, Della-Torre, Emanuel, Maritati, Federica, Peyronel, Francesco, Schleinitz, Nicolas, Urban, Maria L., Vaglio, Augusto   +6 more
core   +1 more source

International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease. [PDF]

, 2020
Castleman disease (CD) includes a group of rare and heterogeneous disorders with characteristic lymph node histopathological abnormalities. CD can occur in a single lymph node station, which is referred to as unicentric CD (UCD).
Bowne, Wilbur, Brandstadter, Joshua, Casper, Corey, Chadburn, Amy, Chandrakasan, Shanmuganathan, Dispenzieri, Angela, Elenitoba-Johnson, Kojo S, Fajgenbaum, David C, Fössa, Alexander, Greenway, Amy, Ide, Makoto, Kurzrock, Razelle, Lechowicz, Mary Jo, Lim, Megan, Maillard, Ivan, Munshi, Nikhil, Nasta, Sunita, Oksenhendler, Eric, Parente, Sophia, Pierson, Sheila K, Schey, Stephen, Srkalovic, Gordan, Streetly, Matthew, Uldrick, Thomas S, van Rhee, Frits, Voorhees, Peter, Wong, Raymond, Wu, David, Yoshizaki, Kazuyuki   +28 more
core   +1 more source

TAFRO syndrome is associated with anti-SSA/Ro60 antibodies, in contrast to idiopathic castleman disease

Scientific Reports
TAFRO syndrome is an acute systemic inflammatory disease characterized by thrombocytopenia, anasarca, fever, reticulin fibrosis/renal dysfunction, and organomegaly.
Mirei Shirakashi, Yuri Nishida, Ran Nakashima, Masakazu Fujimoto, Ryosuke Hiwa, Hideaki Tsuji, Koji Kitagori, Shuji Akizuki, Akio Morinobu, Hajime Yoshifuji   +9 more
doaj   +1 more source

Taking Control of Castleman Disease: Leveraging Precision Medicine Technologies to Accelerate Rare Disease Research [PDF]

, 2015
Castleman disease (CD) is a rare and heterogeneous disorder characterized by lymphadenopathy that may occur in a single lymph node (unicentric) or multiple lymph nodes (multicentric), the latter typically occurring secondary to excessive proinflammatory ...
Carreras Tartak, Jossie A., Croglio, Michael P., Fajgenbaum, David C., Jayanthan, Raj K., Liu, Amy Y., Mitchell, Grant W., Newman, Samantha Kass, Oyeniran, Enny, Razzo, Beatrice M., Ruth, Jason R., Suarez, Alexander   +10 more
core  

Dynamics of Serum Cytokines and Chemokines in Patients With Idiopathic Multicentric Castleman Disease: From a Phase Ib Investigator-Initiated Trial of Filgotinib

Cureus
Background Idiopathic multicentric Castleman disease (iMCD) is a chronic inflammatory condition for which Janus kinase (JAK) inhibition has been hypothesized to be a potential treatment.
S. Fukui, R. Sumiyoshi, Tomohiro Koga, N. Hosogaya, Sawana Narita, Shimpei Morimoto, Hiroshi Yano, Atsushi Katsube, S. Yano, Y. Masaki, Shinichiro Tsunoda, S. Sato, Kiyoshi Migita, A. Kawakami   +13 more
semanticscholar   +1 more source